PI
TMO icon

Parkside Investments’s Thermo Fisher Scientific TMO Stock Holding History

Parkside Investments’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.47M Buy
16,894
+625
+4% +$300K 0.94% 31
2026
Q1 		$8M Buy
16,269
+410
+3% +$223K 0.97% 31
2025
Q4 		$9.19M Sell
15,859
-764
-5% -$432K 1.16% 27
2025
Q3 		$8.06M Sell
16,623
-185
-1% -$86.1K 1.01% 30
2025
Q2 		$6.81M Buy
16,808
+2,280
+16% +$953K 0.93% 36
2025
Q1 		$7.23M Buy
14,528
+161
+1% +$87.2K 1.06% 36
2024
Q4 		$7.47M Sell
14,367
-4
-0% -$2.2K 1.12% 36
2024
Q3 		$8.89M Buy
14,371
+198
+1% +$117K 1.34% 29
2024
Q2 		$7.84M Sell
14,173
-15
-0.1% -$8.59K 1.24% 34
2024
Q1 		$8.25M Sell
14,188
-69
-0.5% -$38.7K 1.31% 32
2023
Q4 		$7.57M Buy
14,257
+390
+3% +$189K 1.28% 34
2023
Q3 		$7.02M Buy
13,867
+385
+3% +$205K 1.29% 36
2023
Q2 		$7.03M Sell
13,482
-145
-1% -$78.2K 1.31% 36
2023
Q1 		$7.85M Buy
13,627
+400
+3% +$225K 1.48% 32
2022
Q4 		$7.28M Buy
13,227
+736
+6% +$390K 1.45% 31
2022
Q3 		$6.33M Buy
12,491
+3,980
+47% +$2.23M 1.36% 35
2022
Q2 		$4.62M Buy
8,511
+963
+13% +$530K 0.97% 43
2022
Q1 		$4.46M Buy
7,548
+161
+2% +$92.5K 0.87% 37
2021
Q4 		$4.93M Buy
7,387
+170
+2% +$106K 0.95% 37
2021
Q3 		$4.12M Sell
7,217
-2,970
-29% -$1.63M 0.86% 42
2021
Q2 		$5.14M Buy
10,187
+240
+2% +$113K 0.99% 40
2021
Q1 		$4.54M Buy
9,947
+260
+3% +$124K 0.94% 40
2020
Q4 		$4.51M Buy
9,687
+601
+7% +$282K 1% 39
2020
Q3 		$4.01M Sell
9,086
-2,237
-20% -$924K 1.05% 40
2020
Q2 		$4.1M Buy
11,323
+300
+3% +$101K 1.08% 33
2020
Q1 		$3.13M Sell
11,023
-1,960
-15% -$618K 1.03% 39
2019
Q4 		$4.22M Sell
12,983
-720
-5% -$218K 1.02% 39
2019
Q3 		$3.99M Sell
13,703
-910
-6% -$261K 1.07% 36
2019
Q2 		$4.29M Sell
14,613
-405
-3% -$112K 1.12% 33
2019
Q1 		$4.11M Buy
15,018
+819
+6% +$204K 1.12% 31
2018
Q4 		$3.18M Buy
14,199
+5,050
+55% +$1.18M 1.38% 24
2018
Q3 		$2.23M Sell
9,149
-450
-5% -$104K 1.06% 32
2018
Q2 		$2.22M Sell
9,599
-2,285
-19% -$485K 1.09% 30
2018
Q1 		$2.45M Sell
11,884
-5,400
-31% -$1.13M 1.28% 25
2017
Q4 		$3.28M Sell
17,284
-850
-5% -$163K 1.6% 22
2017
Q3 		$3.43M Sell
18,134
-2,936
-14% -$532K 1.98% 17
2017
Q2 		$3.68M Sell
21,070
-375
-2% -$63K 2.29% 14
2017
Q1 		$3.29M Buy
+21,445
New +$3.28M 2.32% 19

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Parkside Investments's TMO Position: Q2 2026 in Review

Parkside Investments increased its Thermo Fisher Scientific (TMO) stake by 3.8% in Q2 2026, buying an estimated $300K and bringing the position to 16,894 shares worth $8.47M. The position accounts for 0.94% of the portfolio, ranked #31.

Parkside Investments first reported a position in TMO in Q1 2017 and has held it in 38 quarters since. The position peaked at $9.19M in Q4 2025. 910 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Parkside Investments held 16,894 shares of Thermo Fisher Scientific worth $8.47M as of Q2 2026.
  • Parkside Investments bought 625 Thermo Fisher Scientific shares in Q2 2026, an estimated $300K.
  • Thermo Fisher Scientific made up 0.94% of Parkside Investments's portfolio in Q2 2026, its #31 holding.
  • Parkside Investments first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 38 quarters since.
  • Parkside Investments's Thermo Fisher Scientific position peaked at $9.19M in Q4 2025.
  • 910 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Parkside Investments's 13F filing for Q2 2026, filed 13 Jul 2026.